Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Austin Royster

Showing results (1-10 of 9) with videos related to

Pageof 1
Sort By:
Bio-Protocol|September 9, 2022
Purification of Crimean Congo Hemorrhagic Fever Virus (CCHFV) Nucleocapsid Protein Using Detergent Gradient and Free ThawingAustin Royster, Sheema Mir
Plos One|November 22, 2021
A novel approach for the purification of aggregation prone proteinsAustin Royster, Sheema Mir, Mohammad Ayoub Mir
Microbiology Spectrum|March 31, 2025
Development of FRET-based cap-snatching endonuclease assayJeeva Subbiah, Austin Royster, Sheema Mir, et al.
Plos Pathogens|January 8, 2024
Modulations in the host cell proteome by the hantavirus nucleocapsid proteinAustin Royster, Songyang Ren, Saima Ali, et al.
The Journal of Biological Chemistry|February 4, 2023
A novel compound targets the feline infectious peritonitis virus nucleocapsid protein and inhibits viral replication in cell cultureNazleen Mohseni, Austin Royster, Songyang Ren, et al.
Molecular Therapy. Methods & Clinical Development|July 29, 2024
Engineering single-cycle MeV vector for CRISPR-Cas9 gene editingRamya Rallabandi, Brenna Sharp, Spencer Majerus, et al.
Biorxiv : the Preprint Server for Biology|November 24, 2025
Efficient and reliable measles reprogramming platform for the generation of human iPSCSaksham Vashistha, Sarrianna Hoffer, Jessica Dade, et al.
Microbiology Spectrum|May 18, 2023
SARS-CoV-2 Nucleocapsid Protein Is a Potential Therapeutic Target for Anticoronavirus Drug DiscoveryAustin Royster, Songyang Ren, Yutian Ma, et al.
Molecular Therapy. Advances|May 15, 2026
Efficient and reliable measles reprogramming platform for the generation of human iPSCSaksham Vashistha, Sarrianna Hoffer, Jessica Dade, et al.
Pageof 1

Showing results (1-10 of 9) with videos related to

Sort By:
Pageof 1
Bio-Protocol|September 9, 2022
Purification of Crimean Congo Hemorrhagic Fever Virus (CCHFV) Nucleocapsid Protein Using Detergent Gradient and Free ThawingAustin Royster, Sheema Mir
Plos One|November 22, 2021
A novel approach for the purification of aggregation prone proteinsAustin Royster, Sheema Mir, Mohammad Ayoub Mir
Microbiology Spectrum|March 31, 2025
Development of FRET-based cap-snatching endonuclease assayJeeva Subbiah, Austin Royster, Sheema Mir, et al.
Plos Pathogens|January 8, 2024
Modulations in the host cell proteome by the hantavirus nucleocapsid proteinAustin Royster, Songyang Ren, Saima Ali, et al.
The Journal of Biological Chemistry|February 4, 2023
A novel compound targets the feline infectious peritonitis virus nucleocapsid protein and inhibits viral replication in cell cultureNazleen Mohseni, Austin Royster, Songyang Ren, et al.
Molecular Therapy. Methods & Clinical Development|July 29, 2024
Engineering single-cycle MeV vector for CRISPR-Cas9 gene editingRamya Rallabandi, Brenna Sharp, Spencer Majerus, et al.
Biorxiv : the Preprint Server for Biology|November 24, 2025
Efficient and reliable measles reprogramming platform for the generation of human iPSCSaksham Vashistha, Sarrianna Hoffer, Jessica Dade, et al.
Microbiology Spectrum|May 18, 2023
SARS-CoV-2 Nucleocapsid Protein Is a Potential Therapeutic Target for Anticoronavirus Drug DiscoveryAustin Royster, Songyang Ren, Yutian Ma, et al.
Molecular Therapy. Advances|May 15, 2026
Efficient and reliable measles reprogramming platform for the generation of human iPSCSaksham Vashistha, Sarrianna Hoffer, Jessica Dade, et al.
Pageof 1